Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Montage of Rare Disease Day contributors: Baroness Nicola Blackwood (Chair Genomics England), Bina Shah (Founder Project 8p), Emily Crossley (CEO, Duchenne UK), Rose and Zeryk Hacking (rare disease family), Gary Lineker OBE (OHCC Ambassador) and Prof. Chas Bountra.
Rare Disease Day contributors: Baroness Nicola Blackwood (Chair Genomics England), Bina Shah (Founder Project 8p), Emily Crossley (CEO, Duchenne UK), Rose and Zeryk Hacking (rare disease family), Gary Lineker OBE (OHCC Ambassador) and Prof. Chas Bountra.

Rare Diseases affect 350 million people worldwide. There are over 7,000 known rare diseases and only 5% have an approved treatment, presenting a major global challenge.

Rare Disease Day is an annual international event raising awareness of rare diseases and their impact on the lives of millions. This year, Oxford hosted a webinar as part of the global virtual event series.  The Oxford-Harrington Rare Disease Centre (OHC), a partnership with the Harrington Discovery Institute in the University’s Department of Paediatrics, brings together Oxford’s significant rare disease expertise across departments.

The OHC hosted a guest lecture by the University’s Pro-Vice Chancellor for Innovation, Prof. Chas Bountra, entitled: Lesson from 2020: Together we can do the impossible, for Rare Disease Day. Highlighting the importance of collaboration, Prof. Bountra talked about how 2020 showed that, with the alignment of stakeholders and resources, what would have taken decades to achieve in the past can now be achieved in months. Years of research and infrastructure development in the University provide the foundations of an effective and rapid response to emerging challenges, whether the COVID pandemic or the global unmet need for rare disease treatments. The Department of Paediatrics hosts Oxford’s COVID-19 vaccine trials, where trials in children have now started.

Baroness Nicola Blackwood offered a message of support. From her own diagnostic journey and with her perspective as Chair of Genomics England, she shared her hope that expansion of genomic sequencing in patients and collaboration with the OHC will deliver much-needed treatments for multiple rare diseases.

Insights from rare disease patients and carers included Gary Lineker OBE, an OHC Ambassador, whose two-month-old son was diagnosed with, and subsequently cured of, a rare blood cancer.

Follow @OHRareDisease to keep up to date with news from The Oxford-Harrington Rare Disease Centre.

Similar stories

Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age

A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.

Drug could help diabetic hearts recover after heart attack - Oxford research

Researchers at the University of Oxford have identified a drug that could ultimately help improve heart function in people with diabetes who have heart attacks.

Largest ever global study of tuberculosis identifies genetic causes of drug resistance

Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments.

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.